Joint Formulary & PAD

Ledipasvir/sofosbuvir - Hepatitis C

You are here : Home > Formulary Search > Ledipasvir/sofosbuvir - Hepatitis C

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Granules
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NHSE
NICE
R
SPC
Restrictions / Comments :
Important

Only commissioned from RSFT.

Documents :
 
NICE Technology Appraisal
Ledipasvir–sofosbuvir for treating chronic hepatitis C - NICE TA363

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ledipasvir/sofosbuvir
Indication :
Hepatitis C
Group Name :
Keywords :
antiviral, chronic hepatitis C, Hep C infection
Brand Names Include :
Harvoni
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Ledipasvir/sofosbuvir is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hepatitis C.